Health benefits of fenugreek (Trigonella foenum-graecum leguminosse)

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 425-435

  Basu, Tapan K ^a   Srichamroen, Anchalee ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

4 hydroxy isolucine; Fenugreek seed; Galactomannan; Hypoglycemic; Hypolipidemic.; Metabolic syndrome; Steroidal saponin

Indexed keywords

EID: 77954766926     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374628-3.00028-1     Document Type: Chapter

References (45)

1. Abdel-Nabey A.A., Damir A.A. Changes in some nutrients of fenugreek (Trigonella foenum graecum) seeds during boiling. Plant Foods for Human Nutrition 1990, 40:267-274.
2. Sorengarten F., The Book of Spices 1969, 250-253. Livingston Publishing Company, PA.
3. Leung A.Y., Foster S. Encylopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics 1996, New York: John Wiley & Sons, pp. 243-245. 2nd ed.
4. Patil S.P., Niphadkar P.V., Bhat M.M. Allergy to fenugreek (Trigonella foenum graecum). Annals of Allergy Asthma Immunology 1997, 78:297-300.
5. Fazli F.R.Y., Hardman R. The spice, fenugreek (Trigonella foenum graecum): Its commercial varieties of seed as a source of diosgenin. Tropical Science 1968, 10:66-78.
6. Al-Habori M., Raman A. Antidiabetic and hypocholesterolemic effects of fenugreek. Phytotherapy Research 1998, 12:233-242.
7. Gupta K., Kumar N., Dahiya D.S. Changes in structural carbohydrates and minerals in developing fenugreek (Trigonella foenum graecum) leaves. International Journal of Tropical Agriculture 1998, 16:221-227.
8. Gupta U., Rati E.R., Joseph R. Nutritional quality of lactic acid fermented bitter gourd and fenugreek leaves. International Journal of Food Sciences and Nutrition 1998, 49:101-108.
9. Sauvaire Y., Baccou J.C. Nutritional value of the proteins of a leguminous seed: Fenugreek (Trigonella foenum graecum). Nutrition Reports International 1976, 14:527-537.
10. Mishkinsky J., Joseph B., Sulman F. Hypoglycaemic effect of trigonelline. Lancet 1967, 1:1311-1312.
11. Shani J., Goldschmied A., Ahronson Z., Sulman F.G. Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis seeds and their major alkaoids in alloxan diabetic and normal rats. Archives Internationales DE Pharmacodynamie Therapie 1974, 210:27-36.
12. Dawidar A.M., Saleh A.A., Elmotei S.L. Steroid sapogenin constituents of fenugreek seeds. Planta Medica 1973, 24:367-370.
13. Fourier F. Plantes medicinales et venereuses de France. Paris 1948, 111:495.
14. Ribes G., Sauvaire Y., Da Costa C., Baccou J.C., Loubatieres-Mariani M.M. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proceedings of the Society for Experimental Biology and Medicine 1986, 182:159-166.
15. Amin R., Abdul-Ghani A.S., Suleiman M.S. Effect of fenugreek and lupin seeds on the development of experimental diabetes in rats. Planta Medica 1988, 54:286-290.
16. Madar Z., Abel R., Samish S., Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetes. European Journal of Clinical Nutrition 1988, 42:51-54.
17. Sharma R., Raghuram T.C. Hypoglycemic effect of fenugreek seeds in non-insulin dependent diabetic subjects. Nutrition Research 1990, 10:731-739.
18. Madar Z., Shomer I. Polysaccharide composition of a gel fraction derived from fenugreek and its effects on starch digestion and bile acid absorption in rats. Journal of Agriculture and Food Chemistry 1990, 38:1535-1539.
19. Stark A., Madar Z. The effect of an ethanol extract derived from fenugreek (Trigonella foenum graecum) on bile acid absorption and cholesterol levels in rats. British Journal of Nutrition 1993, 69:277-287.
20. Sauvaire Y., Petit P., Broca C., Manteghetti M., Baissac Y., Fernandea-Alvarez J., Gross R., Roy M., Leconte A., Gomis R., Ribes G. 4-hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes 1998, 47:206-210.
21. Broca C., Gross R., Petit P., Saauvaire Y., Manteghetti M., Tournier M., Masiello P., Gomis R., Ribes G. 4-hydroxyisoleucine: Experimental evidence of its insulinotropic and antidiabetic properties. American Journal Physiology 1999, 277:E617-E623.
22. Broca C., Manteghetti M., Gross R., Baissac Y., Jacob M., Petit P., Sauvaire Y., Ribes G. 4-hydroxyisoleucine: Effects of synthetic and natural analogues on insulin secretion. European Journal of Pharmacology 2000, 390:339-345.
23. Evans A.J., Hood R.L., Oakenfull D.G., Sidhu G.S. Relationship between structure and function of dietary fiber: A comparative study of three galactomannans on cholesterol metabolism in rats. British Journal Nutrition 1992, 68:217-229.
24. Gupta D., Raja J., Baquer N.Z. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: Effect of antidiabetic compounds. Indian Journal of Experimental Biology 1999, 37:196-199.
25. Jennings A.M., Wilson R.M., Ward J.D. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycaemic agents. Diabetes Care 1989, 12:203-208.
26. Buckeridge M.S., Panegassi V.R., Rocha D.C., Dietrich S.M.C. Seed galactomannan in the classification and evolution of the leguminosae. Phytochem 1995, 38:871-875.
27. Maier H., Anderson M., Karl C., Magnuson K., Whistler R.L. Polysaccharides and their derivatives. Industrial Gums 1993, 181-227. Academic Press, San Diego. R.L. Whistler, J.N. BeMiller (Eds.).
28. Garti N., Madar Z., Aserin A., Sterneim B. Fenugreek galactomannan as food emulsifiers. Food Science and Technology 1997, 30:305-311.
29. Groop P.H., Aro A., Stenman S., Groop L. Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. American Journal of Clinical Nutrition 1993, 58:513-518.
30. Massimino S.P., McBurney M.I., Field C.J., Thomson A.B.R., Keelan M., Hayek M.G., Sunvold G.D. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. Journal of Nutrition 1998, 128:1786-1793.
31. Vuksan V., Sievenpipier J.L., Xu Z., Wong E.Y.Y., Jenkins A.L., Beljan-Zdravkovic U., Leiter L.A., Josse R.G., Starvo M.P. Konjac-mannan and American ginsing: Emerging alternate therapies for Type-2 diabetes mellitus. Journal of American College of Nutrition 2001, 20:370S-380S.
32. Srichamroen, A. (2007). Hypoglycemic and hypolipedimic effects of galactomannan from fenugreek (Trigonella foenum graicum L.) grown in Canada. PhD Thesis, Canada: University of Alberta.
33. Srichamroen A., Thomson A.B.R., Field C.J., Basu T.K. In vitro intestinal glucose uptake is inhibited by galactomannan from Canadian fenugreek seed (Trigonella foenum graecum L) in genetically lean and obese rats. Nutrition Research 2009, 29:49-54.
34. O'Brien S.F., Russell J.C. Insulin resistance and vascular wall function: Lessons from animal models. Endocrinology and Metabolism (London) 1997, 4:155-162.
35. Srichamroen A., Thomson A.B.R., Field C.J., Basu T.K. The modifying effects of galactomannan from Canadian-grown fenugreek (Trigonella foenum-graecum L.) on the glycemic and lipidemic status in rats. Journal of Clinical Biochemistry and Nutrition 2008, 43:167-174.
36. Aghelli N., Kabir M., Berni-Canani S., Petijen E., Boussairi A., Luo J., Bornet F., Slama G., Rikzalla S. Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. Journal of Nutrition 1998, 128:1283-1288.
37. Petit P.R., Sauvaire Y.D., Hillaire-Buys D.M. Steroid saponins from fenugreek seeds: Extraction, purification, and pharmacological investigation on feeding behavior and plasma cholesterol. Steroids 1995, 60:674-680.
38. Sidhu G.S., Oakenfull D.G. A mechanism for the hypocholesterolemic activity of saponins. British Journal of Nutrition 1986, 55:643-649.
39. Bhaumick D., Acharya S., Basu T.K. The potential benefits of saponin from Canadian-grown fenugreek (Trigonella foenum graecum L.) in modifying cholesterol status. World Heart Journal 2009, 1:263-270.
40. Francis G., Kerem Z., Makkar H.P.S., Becker K. The biological action of saponins in animal systems: A review. British Journal of Nutrition 2002, 88:587-605.
41. Shani J., Goldschmied A., Ahronson Z., Sulman F.G. Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis seeds and their major alkaloids in alloxan diabetic and normal rats. Archives Internationales De Pharmacodynamie Et De Therapie 1974, 210:27-36.
42. Panda S., Tahiliani P., Kar A. Inhibition of triiodothyronine production by fenugreek seed extract in mice and rats. Pharmacological Research 1999, 40:405-408.
43. Gupta D., Raja J., Baquer N.Z. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: Effect of antidiabetic compounds. Indian Journal of Experimental Biology 1999, 37:196-199.
44. Johnston P.S., ConiffR.F., Hoogwerf B.J., Santiago J.V., Sunyer F.X., Krol A. Effects of the carbohydrate inhibitor miglitol in sulphonulurea-treated NIDDM patients. Diabetes Care 1994, 17:20-29.
45. Camacho P., Pitale S., Abraira C. Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus. Drugs Aging 2000, 17:463-476.